Aggregate data of inmates released from RIDOC, counts of naloxone provided to inmates after release, and the monthly receipt of MAT were also reported. Descriptive statistics of decedents include summarized demographics, the status of incarceration, and the number of fentanyl-related overdoses.
Decedents were defined as individuals who were recently incarcerated if they died within 12 months of release from RIDOC. We conducted a retrospective cohort analysis linking data from the Rhode Island Office of State Medical Examiners for all unintentional deaths from overdose occurring from January 1 to June 30, 2016, and from January 1 to June 30, 2017, to data from RIDOC inmate releases. This analysis examines preliminary association of the program with overall overdose fatalities and deaths from overdose among those individuals who were recently incarcerated. Contemporaneously, a system of 12 community-located Centers of Excellence in MAT was established to promote transitions and referrals of inmates released from RIDOC. Individuals arriving into RIDOC while receiving MAT were to be maintained on their respective medications regimen without tapering or discontinuing their medications. A community vendor with statewide capacity to provide MAT after release was engaged to help run the program in November 2016, and all sites were operational by January 2017. In July 2016, a new model of screening and protocoled treatment with MAT (including methadone, buprenorphine, or naltrexone) launched at the Rhode Island Department of Corrections (RIDOC), a unified prison/jail. 2 This is especially unfortunate given the higher rates of opioid overdose immediately after release from incarceration. Most US correctional facilities do not continue or initiate medications for addiction treatment (MAT). Shared Decision Making and CommunicationĪs the epidemic of opioid use in the United States continues to shift from prescription opioids to illicit drugs, 1 more people living with opioid use disorder are encountering the criminal justice system.Scientific Discovery and the Future of Medicine.Health Care Economics, Insurance, Payment.Clinical Implications of Basic Neuroscience.
Challenges in Clinical Electrocardiography.
0 kommentar(er)
